Sign In

J. Carlo Hojilla, RN, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3631 (phone)
carlo.hojilla@kp.org


 

J. Carlo Hojilla, RN, PhD, is a Postdoctoral Research Fellow in the Drug Abuse Treatment and Services Research Training Program at the University of California San Francisco (UCSF), and at the KPNC Division of Research. He received his PhD at UCSF, his master's at the University of California Los Angeles (UCLA), and his bachelor's degree in nursing at California State University, Los Angeles.

Hojilla is interested in HIV/AIDS research with a particular interest in developing interventions to optimize the delivery of biomedical HIV prevention strategies like pre-exposure prophylaxis (PrEP) in high-priority populations. His research interests focus on documenting factors affecting the PrEP continuum, particularly psychosocial vulnerabilities like substance use, and leveraging novel strategies to support PrEP adherence and retention.

​

Current Position(s):

  • Postdoctoral Research Fellow, Division of Research, Kaiser Permanente Northern California
  • Postdoctoral Research Fellow, Drug Abuse Treatment and Services Research Training Program, Department of Psychiatry, UCSF
  • Nurse coordinator, Kaiser Permanente Northern California Multispecialty Transitions Clinic

Section Affiliations:

Primary Research Interests:

  • HIV pre-exposure prophylaxis
  • Stimulant use
  • Transgender Health

    No results found matching criteria
    No results found matching criteria

    The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system

    Author(s): Satre DD; Sterling SA; Young-Wolff KC; Lam JO; Alexeeff S; Hojilla JC; Weisner C; Silverberg MJ; et al.

    Drug Alcohol Depend. 2021 Feb 01;219:108481. Epub 2021-01-08.

    PubMed abstract

    Comparison of dementia risk after age 50 between individuals with and without HIV infection

    Author(s): Lam JO; Hou CE; Hojilla JC; Anderson AN; Gilsanz P; Alexeeff SE; Levine-Hall T; Hood N; Lee C; Satre DD; Silverberg MJ

    AIDS. 2020 Dec 30;Publish Ahead of Print. Epub 2020-12-30.

    PubMed abstract

    Screening for Gender Identity in Adolescent Well Visits: Is It Feasible and Acceptable?

    Author(s): Lau JS; Kline-Simon A; Sterling S; Hojilla JC; Hartman L

    J Adolesc Health. 2020 Aug 22.

    PubMed abstract

    HIV Stigma and Its Associations with Longitudinal Health Outcomes Among Persons Living with HIV with a History of Unhealthy Alcohol Use

    Author(s): Hojilla JC; Santiago-Rodriguez EI; Sterling S; Williams EC; Leyden W; Hare CB; Silverberg MJ; Satre DD

    AIDS Behav. 2020 Jul 06.

    PubMed abstract

    Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco

    Author(s): Hojilla JC; Marcus JL; Silverberg MJ; Hare CB; Herbers R; Hurley L; Satre DD; Volk JE

    Clin Infect Dis. 2020 Jun 04.

    PubMed abstract

    Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data

    Author(s): Satre DD; Sarovar V; Leyden W; Hare CB; Catz SL; Bryant KJ; Williams EC; Hojilla JC; Horberg MA; Silverberg MJ

    AIDS Behav. 2019 Nov 26.

    PubMed abstract

    Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV

    Author(s): Hojilla JC; Marcus J; Volk JE; Leyden W; Hare CB; Hechter RC; Edelman EJ; Silverberg M; Satre DD

    Sex Transm Infect. 2019 Aug 23.

    PubMed abstract

    Effectiveness of a Gender Affirming Surgery Class for Transgender and non-binary Patients and their Caregivers in an Integrated Healthcare Setting

    Author(s): Poceta J; Cousins S; Wenzel C; Lakhardt K; Hojilla C; Marlowe L; Ayoob J; Weintraub MR; Zaritsky EF

    Int J Transgend. 2019;20(1):81-86. Epub 2019-03-11.

    PubMed abstract